179 related articles for article (PubMed ID: 12845677)
1. Germline 657del5 mutation in the NBS1 gene in breast cancer patients.
Górski B; Debniak T; Masojć B; Mierzejewski M; Medrek K; Cybulski C; Jakubowska A; Kurzawski G; Chosia M; Scott R; Lubiński J
Int J Cancer; 2003 Sep; 106(3):379-81. PubMed ID: 12845677
[TBL] [Abstract][Full Text] [Related]
2. Germline 657del5 mutation in the NBS1 gene in patients with malignant melanoma of the skin.
Debniak T; Górski B; Cybulski C; Jakubowska A; Kurzawski G; Lener M; Mierzejewski M; Masojć B; Medrek K; Kładny J; Załuga E; Maleszka R; Chosia M; Lubiński J
Melanoma Res; 2003 Aug; 13(4):365-70. PubMed ID: 12883362
[TBL] [Abstract][Full Text] [Related]
3. NBS1 657del5 mutation may contribute only to a limited fraction of breast cancer cases in Russia.
Buslov KG; Iyevleva AG; Chekmariova EV; Suspitsin EN; Togo AV; Kuligina ESh; Sokolenko AP; Matsko DE; Turkevich EA; Lazareva YR; Chagunava OL; Bit-Sava EM; Semiglazov VF; Devilee P; Cornelisse C; Hanson KP; Imyanitov EN
Int J Cancer; 2005 Apr; 114(4):585-9. PubMed ID: 15578693
[TBL] [Abstract][Full Text] [Related]
4. I171V germline mutation in the NBS1 gene significantly increases risk of breast cancer.
Roznowski K; Januszkiewicz-Lewandowska D; Mosor M; Pernak M; Litwiniuk M; Nowak J
Breast Cancer Res Treat; 2008 Jul; 110(2):343-8. PubMed ID: 17899368
[TBL] [Abstract][Full Text] [Related]
5. Germline mutations 657del5 of the NBS1 gene contribute significantly to the incidence of breast cancer in Central Poland.
Steffen J; Nowakowska D; Niwińska A; Czapczak D; Kluska A; Piatkowska M; Wiśniewska A; Paszko Z
Int J Cancer; 2006 Jul; 119(2):472-5. PubMed ID: 16770759
[TBL] [Abstract][Full Text] [Related]
6. Germline NBS1 mutations in families with aggregation of Breast and/or ovarian cancer from north-east Poland.
Kanka C; Brozek I; Skalska B; Siemiatkowska A; Limon J
Anticancer Res; 2007; 27(4C):3015-8. PubMed ID: 17695489
[TBL] [Abstract][Full Text] [Related]
7. Increased cancer risk of heterozygotes with NBS1 germline mutations in Poland.
Steffen J; Varon R; Mosor M; Maneva G; Maurer M; Stumm M; Nowakowska D; Rubach M; Kosakowska E; Ruka W; Nowecki Z; Rutkowski P; Demkow T; Sadowska M; Bidziński M; Gawrychowski K; Sperling K
Int J Cancer; 2004 Aug; 111(1):67-71. PubMed ID: 15185344
[TBL] [Abstract][Full Text] [Related]
8. Mutation analysis and characterization of ATR sequence variants in breast cancer cases from high-risk French Canadian breast/ovarian cancer families.
Durocher F; Labrie Y; Soucy P; Sinilnikova O; Labuda D; Bessette P; Chiquette J; Laframboise R; Lépine J; Lespérance B; Ouellette G; Pichette R; Plante M; Tavtigian SV; Simard J
BMC Cancer; 2006 Sep; 6():230. PubMed ID: 17010193
[TBL] [Abstract][Full Text] [Related]
9. Cancer risk of heterozygotes with the NBN founder mutation.
Seemanová E; Jarolim P; Seeman P; Varon R; Digweed M; Swift M; Sperling K
J Natl Cancer Inst; 2007 Dec; 99(24):1875-80. PubMed ID: 18073374
[TBL] [Abstract][Full Text] [Related]
10. Nijmegen breakage syndrome gene (NBS1) alterations and its protein (nibrin) expression in human ovarian tumours.
Plisiecka-Hałasa J; Dansonka-Mieszkowska A; Rembiszewska A; Bidziński M; Steffen J; Kupryjańczyk J
Ann Hum Genet; 2002 Nov; 66(Pt 5-6):353-9. PubMed ID: 12485469
[TBL] [Abstract][Full Text] [Related]
11. Nijmegen Breakage Syndrome mutations and risk of breast cancer.
Bogdanova N; Feshchenko S; Schürmann P; Waltes R; Wieland B; Hillemanns P; Rogov YI; Dammann O; Bremer M; Karstens JH; Sohn C; Varon R; Dörk T
Int J Cancer; 2008 Feb; 122(4):802-6. PubMed ID: 17957789
[TBL] [Abstract][Full Text] [Related]
12. Analysis of the FHIT gene and FRA3B region in sporadic breast cancer, preneoplastic lesions, and familial breast cancer probands.
Ahmadian M; Wistuba II; Fong KM; Behrens C; Kodagoda DR; Saboorian MH; Shay J; Tomlinson GE; Blum J; Minna JD; Gazdar AF
Cancer Res; 1997 Sep; 57(17):3664-8. PubMed ID: 9288768
[TBL] [Abstract][Full Text] [Related]
13. Double heterozygotes among breast cancer patients analyzed for BRCA1, CHEK2, ATM, NBN/NBS1, and BLM germ-line mutations.
Sokolenko AP; Bogdanova N; Kluzniak W; Preobrazhenskaya EV; Kuligina ES; Iyevleva AG; Aleksakhina SN; Mitiushkina NV; Gorodnova TV; Bessonov AA; Togo AV; Lubiński J; Cybulski C; Jakubowska A; Dörk T; Imyanitov EN
Breast Cancer Res Treat; 2014 Jun; 145(2):553-62. PubMed ID: 24800916
[TBL] [Abstract][Full Text] [Related]
14. Role of the Nijmegen breakage syndrome 1 gene in familial and sporadic prostate cancer.
Hebbring SJ; Fredriksson H; White KA; Maier C; Ewing C; McDonnell SK; Jacobsen SJ; Cerhan J; Schaid DJ; Ikonen T; Autio V; Tammela TL; Herkommer K; Paiss T; Vogel W; Gielzak M; Sauvageot J; Schleutker J; Cooney KA; Isaacs W; Thibodeau SN
Cancer Epidemiol Biomarkers Prev; 2006 May; 15(5):935-8. PubMed ID: 16702373
[TBL] [Abstract][Full Text] [Related]
15. Loss of heterozygosity in bilateral breast cancer.
Kollias J; Man S; Marafie M; Carpenter K; Pinder S; Ellis IO; Blamey RW; Cross G; Brook JD
Breast Cancer Res Treat; 2000 Dec; 64(3):241-51. PubMed ID: 11200774
[TBL] [Abstract][Full Text] [Related]
16. High-risk human papilloma virus infection, tumor pathophenotypes, and BRCA1/2 and TP53 status in juvenile breast cancer.
Aceto GM; Solano AR; Neuman MI; Veschi S; Morgano A; Malatesta S; Chacon RD; Pupareli C; Lombardi M; Battista P; Marchetti A; Mariani-Costantini R; Podestà EJ
Breast Cancer Res Treat; 2010 Aug; 122(3):671-83. PubMed ID: 19851859
[TBL] [Abstract][Full Text] [Related]
17. p27/Kip1 mutation found in breast cancer.
Spirin KS; Simpson JF; Takeuchi S; Kawamata N; Miller CW; Koeffler HP
Cancer Res; 1996 May; 56(10):2400-4. PubMed ID: 8625318
[TBL] [Abstract][Full Text] [Related]
18. Increased risk of gastrointestinal lymphoma in carriers of the 657del5 NBS1 gene mutation.
Steffen J; Maneva G; Popławska L; Varon R; Mioduszewska O; Sperling K
Int J Cancer; 2006 Dec; 119(12):2970-3. PubMed ID: 16998789
[TBL] [Abstract][Full Text] [Related]
19. Novel somatic mutations in the BRCA1 gene in sporadic breast tumors.
Janatova M; Zikan M; Dundr P; Matous B; Pohlreich P
Hum Mutat; 2005 Mar; 25(3):319. PubMed ID: 15712267
[TBL] [Abstract][Full Text] [Related]
20. NBS1 is a prostate cancer susceptibility gene.
Cybulski C; Górski B; Debniak T; Gliniewicz B; Mierzejewski M; Masojć B; Jakubowska A; Matyjasik J; Złowocka E; Sikorski A; Narod SA; Lubiński J
Cancer Res; 2004 Feb; 64(4):1215-9. PubMed ID: 14973119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]